Hetero Labs Limited Thalidomide Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Thalidomide Export Records India — #6 Exporter, 8 Shipments, $86.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Thalidomide

India Pharmaceutical Trade Intelligence

$1.9M153 Suppliers92 CountriesHS 30049049

ExportsIndia → ALGERIA26.8%India → SRI LANKA14.5%

ImportsUNITED KINGDOM → India$105

#1 Supplier: BDR PHARMACEUTICALS #1 Buyer: SOFTCARE INTERNATIONAL(PVT)LTD

Hetero Labs Limited — Thalidomide Exporter #6 | $86.6K Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Thalidomide Exporter Profile

Indian Pharmaceutical Exporter · #6 for Thalidomide · $86.6K export value · DGFT Verified

Hetero Labs Limited is the #6 Indian exporter of Thalidomide with $86.6K in export value and 8 verified shipments. Hetero Labs Limited holds a 4.5% market share in Thalidomide exports across 4 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Thalidomide Export Profile: Buyers & Destinations

Hetero Labs Limited Thalidomide export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Thalidomide?

Country	Value	Shipments	Share
ALGERIA	$518.2K	25	31.3%
SRI LANKA	$280.1K	25	16.9%
SERBIA	$266.4K	13	16.1%
VIETNAM	$223.5K	9	13.5%

Who Are the Top Buyers of Thalidomide from India?

Buyer	Country	Value	Orders
SOFTCARE INTERNATIONAL(PVT)LTD	SRI LANKA	$251.3K	10
PHCEDEHO	ALGERIA	$225.1K	9
VIETNAM MEDICAL PRODUCTS IMPORT-	VIETNAM	$159.7K	4
PHCEDEHOP	ALGERIA	$132.4K	6
PHCEDEHOP PHARMACIE CENTRALE DES HOPITAUX DAREL BEIDA ALGIERS ALGIERS	ALGERIA	$111.0K	7
RHEI LIFE D.O.O BEOGRAD	SERBIA	$92.9K	3
DELTA IMPORT EXPORT MEDICAL COMPANY	VIETNAM	$62.5K	4
SOPHARMA TRADING HEAD OFFICE	SERBIA	$62.4K	4
PHARMACIE NATIONALE D'APPROVISIONNE	SENEGAL	$58.5K	4
PHARMACIE CENTRALE DES HOPITAUX	ALGERIA	$37.5K	2

India's Thalidomide is purchased by 256 buyers worldwide. The top buyer is SOFTCARE INTERNATIONAL(PVT)LTD (SRI LANKA), followed by PHCEDEHO and VIETNAM MEDICAL PRODUCTS IMPORT-.

How Does Hetero Labs Limited Compare to Nearest Thalidomide Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$142.5K	6	2	$23.8K
5	KANCHAN SAGAR PHARMACEUTICALS	$98.7K	5	1	$19.7K
6	HETERO LABS LIMITED ★	$86.6K	8	4	$10.8K
7	ACCURE LABS PRIVATE LIMITED	$74.5K	4	1	$18.6K
8	3S PHARMACEUTICALS INDIA PRIVATE LIMITED	$34.7K	34	5	$1.0K

Hetero Labs Limited ranks #6 among 153 Indian Thalidomide exporters. Average shipment value of $10.8K compared to the market average of $10.3K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and KANCHAN SAGAR PHARMACEUTICALS.

Which Indian Ports Ship Thalidomide Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	215	26.2%
SAHAR AIR	188	22.9%
Bombay Air	83	10.1%
DELHI AIR CARGO ACC (INDEL4)	65	7.9%
DELHI AIR	63	7.7%
Bombay Air Cargo	33	4.0%
AHEMDABAD AIR	28	3.4%
AHEMDABAD AIR ACC (INAMD4)	14	1.7%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Thalidomide Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Thalidomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 92+ countries, 256+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Thalidomide

Thalidomide

Hetero Labs Limited — Thalidomide Exporter Profile

Hetero Labs Limited — Thalidomide Export Profile: Buyers & Destinations

Where Does India Export Thalidomide?

Who Are the Top Buyers of Thalidomide from India?

What Is India's Total Thalidomide Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Thalidomide Exports?

How Does Hetero Labs Limited Compare to Other Indian Thalidomide Exporters?

How Does Hetero Labs Limited Compare to Nearest Thalidomide Exporters?

Which Indian Ports Ship Thalidomide Exports?

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Thalidomide Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Thalidomide Export Data from Hetero Labs Limited

Thalidomide Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source